Filtered By:
Source: EuroIntervention
Condition: Heart Valve Disease

This page shows you your search results in order of date.

Order by Relevance | Date

Total 25 results found since Jan 2013.

Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR
CONCLUSIONS: Preliminary results from the FIH study with DurAVR THV demonstrate a good safety profile with promising haemodynamic performance sustained at 1 year and restoration of near-normal flow dynamics. Further clinical investigation is warranted to evaluate how DurAVR THV may play a role in addressing the challenge of lifetime management in AS patients.PMID:37334801 | DOI:10.4244/EIJ-D-23-00282
Source: EuroIntervention - June 19, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Susheel K Kodali Paul Sorajja Christopher U Meduri Kari Feldt Jo ão L Cavalcante Pankaj Garg Nadira Hamid Karl K Poon Magnus R M Settergren Marcus R Burns Andreas R ück Janarthanan Sathananthan Alan Zajarias Tamaz Shaburishvili Teona Zirakashvili Maia Z Source Type: research

Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study
CONCLUSIONS: The PORTICO NG Study demonstrates low rates of adverse events and PVL up to 1 year in patients at high or extreme surgical risk, confirming the safety and efficacy of the Navitor THV system.PMID:36895190 | DOI:10.4244/EIJ-D-22-01108
Source: EuroIntervention - March 10, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Lars Sondergaard Antony S Walton Stephen G Worthley Dave Smith Bassem Chehab Ganesh Manoharan Gerald Yong Francesco Bedogni Nicholas Bates Michael J Reardon Source Type: research

One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry
CONCLUSIONS: Compared with the S3, the S3U transcatheter heart valve was associated with similar 1-year clinical outcomes but reduced rates of mild PVL.PMID:36880333 | DOI:10.4244/EIJ-D-22-01022
Source: EuroIntervention - March 7, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Stefano Cannata Caterina Gandolfo Flavio L Ribichini Nicolas van Mieghem Sergio Buccheri Marco Barbanti Sergio Berti Rui Campante Teles Antonio L Bartorelli Giuseppe Musumeci Tommaso Piva Luis Nombela-Franco Ketty La Spina Tullio Palmerini Rik Adrichem Au Source Type: research

Clinical outcomes of the ACURATE  neo2 transcatheter heart valve: a prospective, multicenter, observational, post-market surveillance study
CONCLUSIONS: The study results support the safety and efficacy of TAVI with ACURATE neo2 in patients in routine clinical practice.PMID:36440588 | DOI:10.4244/EIJ-D-22-00914
Source: EuroIntervention - November 28, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Corrado Tamburino Helge M öllmann Matteo Montorfano Julia Ellert-Gregersen Tanja K Rudolph Nicolas M Van Mieghem Michael Hilker Ignacio J Amat-Santos Christian Juhl Terkelsen Anna Sonia Petronio Pieter R Stella Matthias G ötberg Andreas R à Source Type: research

Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study
CONCLUSIONS: Dual antithrombotic therapy is associated with a substantially lower risk of clinically relevant bleeding without a statistically significant penalty in ischaemic events.PMID:35370126 | DOI:10.4244/EIJ-D-21-00703
Source: EuroIntervention - April 4, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Willem Lambertus Bor Anne Johanna Wilhelmina de Veer Renske H Olie Sem A O F Rikken Dean R P P Chan Pin Yin Jean Paul R Herrman Mathias Vrolix Martijn Meuwissen Tom Vandendriessche Carlos van Mieghem Michael Magro Naoual Bennaghmouch Rick Hermanides Tom A Source Type: research

Impact of left ventricular outflow tract calcification in patients undergoing transfemoral transcatheter aortic valve implantation
CONCLUSIONS: In patients undergoing TAVI, the presence of significant LVOT calcification is common and associated with worse short-term clinical and functional outcomes as well as higher one-year mortality rates compared to patients w/o LVOT calcification.PMID:34658340 | DOI:10.4244/EIJ-D-21-00464
Source: EuroIntervention - October 18, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Lara Waldschmidt Alina Go ßling Sebastian Ludwig Matthias Linder Lisa Voigtl änder David Grundmann Oliver Daniel Bhadra Till Demal Johannes Schirmer Hermann Reichenspurner Stefan Blankenberg Dirk Westermann Moritz Seiffert Lenard Conradi Niklas Schofer Source Type: research